NCT04856709

Brief Summary

This study aims to compare between abdominal pectopexy and abdominal sacral hysteropexy in terms of efficacy (assessed by POP-Q system), intra and postoperative complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

April 13, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 23, 2021

Completed
Last Updated

April 23, 2021

Status Verified

April 1, 2021

Enrollment Period

1 year

First QC Date

April 13, 2021

Last Update Submit

April 21, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy, After the procedure there will be follow up visits at 3 months to detect the efficacy of the procedure by using POP-Q system.

    The POP-Q system is a technique that measures compartment prolapse relative to the anatomic landmark of the hymen.Prolapse points proximal to the hymen are given a negative value, whereas positive values are given to points that protrude past the hymen. 6 points are delineated, including two on the anterior vaginal wall (Aa, Ba), two on the vaginal apex (C, D), and two on the posterior vaginal wall (Ap, Bp). Points Gh, Pb, and TVL describe the genital hiatus, perineal body, and total vaginal length, respectively. * Stage 0: no demonstrable prolapse * Stage 1: the most distal portion of the prolapsed segment is \>1 cm above the level of the hymen * Stage 2: the most distal portion of the prolapsed segment is \>1 cm or less proximal or distal to the hymen * Stage 3: the most distal portion of the prolapsed segment protrudes \>1 cm below the hymen but 2 cm less than the total length of the vagina * Stage 4: complete eversion of the vagina

    3 months

Secondary Outcomes (5)

  • Operative time

    60- 240 minutes

  • Intra operative blood loss

    60- 240 minutes

  • Intra operative complications

    60- 240 minutes

  • Post operative complications

    1 week

  • Post operative pain

    after 6 hours, 12 hours and 24 hours from the operation

Study Arms (1)

study group

OTHER

Women with stage 2 to 4 uterine prolapse. BMI from ≤ 35 kg\\m2. Women of any parity including nulliparas will be included. Age of female patients ranges from 20 to 40 years.

Procedure: Abdominal PectopexyProcedure: Abdominal Sacral Hysteropexy

Interventions

Pectopexy is a new technique for apical repair in which lateral parts of the iliopectineal ligament are used for cuff or cervix suspension.

study group

Abdominal sacrocolpopexy is a procedure that uses a mesh material to support the top of the vagina to treat pelvic prolapse.

study group

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women with stage 2 to 4 uterine prolapse.
  • BMI from ≤ 35 kg\\m2.
  • Women of any parity including nulliparas will be included.
  • Age of female patients ranges from 20 to 40 years.

You may not qualify if:

  • Previous correction of apical prolapse.
  • Inoperable co-existing uterine pathology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine, Ain Shams University

Cairo, 11591, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: * Study design: Randomized Controlled clinical Trial * Study Setting: Ain Shams maternity hospital. * Study Population: The study included 80 women divided into 2 groups: Group A: 40 women underwent abdominal pectopexy. Group B: 40 women underwent abdominal sacral hysteropexy.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2021

First Posted

April 23, 2021

Study Start

June 1, 2019

Primary Completion

June 1, 2020

Study Completion

April 1, 2021

Last Updated

April 23, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
6 months after publication

Locations